Print ISSN:-

Online ISSN:-2582-1075

Article History

Received : 15-08-2024

Accepted : 24-09-2024



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 56

PDF Downloaded: 11


Nanotechnology in medicine: A comprehensive review of its role in modern drug delivery systems


Full Text PDF


Review Article

Author Details : Supriya Gandotra, Medha Shukla, Preeti Kale*

Volume : 6, Issue : 4, Year : 2024

Article Page : 108-111

https://doi.org/10.18231/j.ijrimcr.2024.060



Suggest article by email

Abstract

Nanotechnology has revolutionized the field of medicine, particularly in the development of modern drug delivery systems. This review provides a comprehensive exploration of the role that nanotechnology plays in enhancing drug delivery mechanisms, targeting specific sites and minimizing side effects. Advances in nanoparticle-based drug carriers, including liposomes, dendrimers and polymeric nanoparticles, offer superior bioavailability, sustained release and improved solubility for various therapeutic agents. The review delves into the latest innovations in nanocarriers, their applications in cancer treatment, gene therapy and infectious diseases and discusses the challenges of clinical translation. Furthermore, it addresses the regulatory, ethical and safety concerns surrounding nanomedicine. By highlighting both the promises and limitations of nanotechnology in drug delivery, this article aims to provide a balanced perspective on its transformative potential in modern healthcare.
Keywords : Nanomedicine, Nanoparticles, Personalized medicine, Targeted drug delivery



How to cite : Gandotra S, Shukla M, Kale P, Nanotechnology in medicine: A comprehensive review of its role in modern drug delivery systems. Int J Recent Innov Med Clin Res 2024;6(4):108-111


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.